Location History:
- Darmstadt, DE (2002)
- Muhltal, DE (1993 - 2004)
- Mühltal, DE (2002 - 2009)
- Muehltal, DE (2004 - 2009)
Company Filing History:
14 out of 1,248 
11 out of 2,937 
3 out of 100 Years Active: 1993-2009
Title: Pierre Schelling: A Pioneer in Pharmaceutical Innovations
Introduction
Pierre Schelling, based in Muehltal, Germany, is a distinguished inventor with an impressive portfolio of 30 patents. His work primarily focuses on the development of novel pharmaceutical compounds aimed at treating a myriad of serious health conditions. Schelling's innovative contributions are essential in the ongoing quest for effective therapies in various medical fields.
Latest Patents
Among his latest patents, one notable innovation includes the development of Hydrazono-malonitriles, specifically hydrazono-malonitrile derivatives recognized as phosphodiesterase IV inhibitors. These compounds hold great potential for treating a range of conditions including osteoporosis, tumors, cachexia, atherosclerosis, rheumatoid arthritis, multiple sclerosis, diabetes mellitus, and inflammatory diseases. Another significant patent details 4-(benzylidene-amino)-3-(methylsulfanyl)-4h-(1,2,4)triazin-5-one derivatives, which also exhibit phosphodiesterase IV inhibition. These derivatives present therapeutic possibilities for treating allergic diseases, asthma, chronic bronchitis, skin diseases, and autoimmune disorders, among others.
Career Highlights
Pierre Schelling has made significant strides in the pharmaceutical industry, holding prominent positions at notable organizations, including Merck Patent Gesellschaft mit beschränkter Haftung and Merck Patent GmbH. His innovative thinking and research prowess have enabled the development of transformative medical solutions that have the potential to enhance patient care.
Collaborations
Throughout his career, Schelling has collaborated with talented individuals including Norbert Beier and Maria Christadler. These partnerships have undoubtedly contributed to his success and the advancement of his research in the pharmaceutical sector.
Conclusion
With 30 patents to his name and groundbreaking work in pharmaceutical innovations, Pierre Schelling stands as a pivotal figure in the field. His latest inventions exemplify the impact of dedicated research and innovation in developing treatments for complex diseases, underscoring the importance of continued investment in pharmaceutical research and development.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.